Software - Application
Compare Stocks
4 / 10Stock Comparison
IBTA vs ACMR vs DSGX vs ICHR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Software - Application
Semiconductors
IBTA vs ACMR vs DSGX vs ICHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Semiconductors | Software - Application | Semiconductors |
| Market Cap | $1.04B | $3.92B | $6.31B | $2.47B |
| Revenue (TTM) | $340M | $901M | $731M | $959M |
| Net Income (TTM) | $-7M | $94M | $164M | $-51M |
| Gross Margin | 78.4% | 44.4% | 71.4% | 11.3% |
| Operating Margin | -2.6% | 12.1% | 30.4% | -3.8% |
| Forward P/E | 305.9x | 29.7x | 39.3x | 62.2x |
| Total Debt | $26M | $303M | $8M | $186M |
| Cash & Equiv. | $187M | $766M | $354M | $98M |
IBTA vs ACMR vs DSGX vs ICHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 24 | May 26 | Return |
|---|---|---|---|
| Ibotta, Inc. (IBTA) | 100 | 35.9 | -64.1% |
| ACM Research, Inc. (ACMR) | 100 | 232.0 | +132.0% |
| The Descartes Syste… (DSGX) | 100 | 79.1 | -20.9% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 183.7 | +83.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IBTA vs ACMR vs DSGX vs ICHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IBTA lags the leaders in this set but could rank higher in a more targeted comparison.
ACMR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 3.24, yield 0.2%
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- 30.7% 10Y total return vs ICHR's 6.3%
- PEG 0.84 vs DSGX's 1.53
DSGX is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.71, Low D/E 0.5%, current ratio 2.16x
- Beta 0.71, current ratio 2.16x
- 22.5% margin vs ICHR's -5.3%
- Beta 0.71 vs ICHR's 3.93, lower leverage
ICHR is the clearest fit if your priority is momentum.
- +329.1% vs DSGX's -31.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs IBTA's -6.8% | |
| Value | Lower P/E (29.7x vs 62.2x) | |
| Quality / Margins | 22.5% margin vs ICHR's -5.3% | |
| Stability / Safety | Beta 0.71 vs ICHR's 3.93, lower leverage | |
| Dividends | 0.2% yield; 3-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +329.1% vs DSGX's -31.7% | |
| Efficiency (ROA) | 9.2% ROA vs ICHR's -5.2%, ROIC 14.9% vs -3.9% |
IBTA vs ACMR vs DSGX vs ICHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IBTA vs ACMR vs DSGX vs ICHR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACMR leads in 3 of 6 categories
DSGX leads 2 • IBTA leads 0 • ICHR leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DSGX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICHR is the larger business by revenue, generating $959M annually — 2.8x IBTA's $340M. DSGX is the more profitable business, keeping 22.5% of every revenue dollar as net income compared to ICHR's -5.3%. On growth, DSGX holds the edge at +17.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $340M | $901M | $731M | $959M |
| EBITDAEarnings before interest/tax | -$3M | $126M | $310M | -$11M |
| Net IncomeAfter-tax profit | -$7M | $94M | $164M | -$51M |
| Free Cash FlowCash after capex | $81M | -$69M | $261M | -$17M |
| Gross MarginGross profit ÷ Revenue | +78.4% | +44.4% | +71.4% | +11.3% |
| Operating MarginEBIT ÷ Revenue | -2.6% | +12.1% | +30.4% | -3.8% |
| Net MarginNet income ÷ Revenue | -2.1% | +10.4% | +22.5% | -5.3% |
| FCF MarginFCF ÷ Revenue | +23.8% | -7.6% | +35.8% | -1.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.5% | +9.4% | +17.2% | +4.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -26.7% | -76.1% | +23.3% | +46.2% |
Valuation Metrics
ACMR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 38.4x trailing earnings, DSGX trades at a 87% valuation discount to IBTA's 305.9x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs DSGX's 1.50x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.0B | $3.9B | $6.3B | $2.5B |
| Enterprise ValueMkt cap + debt − cash | $880M | $3.5B | $6.0B | $2.6B |
| Trailing P/EPrice ÷ TTM EPS | 305.92x | 43.21x | 38.42x | -46.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.68x | 39.34x | 62.25x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.22x | 1.50x | — |
| EV / EBITDAEnterprise value multiple | 88.24x | 27.49x | 18.10x | — |
| Price / SalesMarket cap ÷ Revenue | 3.04x | 4.35x | 8.47x | 2.61x |
| Price / BookPrice ÷ Book value/share | 3.84x | 2.06x | 3.99x | 3.67x |
| Price / FCFMarket cap ÷ FCF | 13.89x | — | 23.71x | — |
Profitability & Efficiency
DSGX leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
DSGX delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-8 for ICHR. DSGX carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ICHR's 0.28x. On the Piotroski fundamental quality scale (0–9), DSGX scores 7/9 vs ACMR's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.4% | +6.1% | +10.7% | -7.5% |
| ROA (TTM)Return on assets | -1.3% | +3.9% | +9.2% | -5.2% |
| ROICReturn on invested capital | +1.1% | +7.0% | +14.9% | -3.9% |
| ROCEReturn on capital employed | +0.4% | +6.6% | +15.6% | -4.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 7 | 3 |
| Debt / EquityFinancial leverage | 0.09x | 0.16x | 0.01x | 0.28x |
| Net DebtTotal debt minus cash | -$161M | -$463M | -$346M | $87M |
| Cash & Equiv.Liquid assets | $187M | $766M | $354M | $98M |
| Total DebtShort + long-term debt | $26M | $303M | $8M | $186M |
| Interest CoverageEBIT ÷ Interest expense | — | 20.44x | 229.22x | -5.97x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $3,555 for IBTA. Over the past 12 months, ICHR leads with a +329.1% total return vs DSGX's -31.7%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs IBTA's -29.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +60.3% | +31.9% | -13.8% | +249.0% |
| 1-Year ReturnPast 12 months | -21.9% | +195.6% | -31.7% | +329.1% |
| 3-Year ReturnCumulative with dividends | -64.4% | +487.9% | -5.1% | +151.1% |
| 5-Year ReturnCumulative with dividends | -64.4% | +133.4% | +19.7% | +28.9% |
| 10-Year ReturnCumulative with dividends | -64.4% | +3065.8% | +295.4% | +629.1% |
| CAGR (3Y)Annualised 3-year return | -29.2% | +80.5% | -1.7% | +35.9% |
Risk & Volatility
Evenly matched — DSGX and ICHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
DSGX is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs IBTA's 58.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 3.24x | 0.71x | 3.93x |
| 52-Week HighHighest price in past year | $62.74 | $71.65 | $117.35 | $72.87 |
| 52-Week LowLowest price in past year | $19.10 | $19.26 | $62.56 | $13.12 |
| % of 52W HighCurrent price vs 52-week peak | +58.5% | +82.6% | +62.5% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 74.1 | 60.7 | 47.7 | 66.9 |
| Avg Volume (50D)Average daily shares traded | 270K | 1.2M | 583K | 795K |
Analyst Outlook
ACMR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: IBTA as "Buy", ACMR as "Buy", DSGX as "Buy", ICHR as "Buy". Consensus price targets imply 121.7% upside for IBTA (target: $81) vs -32.4% for ACMR (target: $40). ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $81.38 | $40.00 | $103.50 | $49.80 |
| # AnalystsCovering analysts | 9 | 10 | 14 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | — | — |
| Dividend StreakConsecutive years of raises | — | 3 | — | 1 |
| Dividend / ShareAnnual DPS | — | $0.11 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +22.4% | +0.2% | +0.0% | 0.0% |
ACMR leads in 3 of 6 categories (Valuation Metrics, Total Returns). DSGX leads in 2 (Income & Cash Flow, Profitability & Efficiency). 1 tied.
IBTA vs ACMR vs DSGX vs ICHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IBTA or ACMR or DSGX or ICHR a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -6. 8% for Ibotta, Inc. (IBTA). The Descartes Systems Group Inc. (DSGX) offers the better valuation at 38. 4x trailing P/E (39. 3x forward), making it the more compelling value choice. Analysts rate Ibotta, Inc. (IBTA) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IBTA or ACMR or DSGX or ICHR?
On trailing P/E, The Descartes Systems Group Inc.
(DSGX) is the cheapest at 38. 4x versus Ibotta, Inc. at 305. 9x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus The Descartes Systems Group Inc. 's 1. 53x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IBTA or ACMR or DSGX or ICHR?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +133. 4%, compared to -64. 4% for Ibotta, Inc. (IBTA). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus IBTA's -64. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IBTA or ACMR or DSGX or ICHR?
By beta (market sensitivity over 5 years), The Descartes Systems Group Inc.
(DSGX) is the lower-risk stock at 0. 71β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 454% more volatile than DSGX relative to the S&P 500. On balance sheet safety, The Descartes Systems Group Inc. (DSGX) carries a lower debt/equity ratio of 1% versus 28% for Ichor Holdings, Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — IBTA or ACMR or DSGX or ICHR?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -6. 8% for Ibotta, Inc. (IBTA). On earnings-per-share growth, the picture is similar: The Descartes Systems Group Inc. grew EPS 16. 5% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IBTA or ACMR or DSGX or ICHR?
The Descartes Systems Group Inc.
(DSGX) is the more profitable company, earning 22. 5% net margin versus -5. 6% for Ichor Holdings, Ltd. — meaning it keeps 22. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DSGX leads at 32. 3% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — IBTA leads at 78. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IBTA or ACMR or DSGX or ICHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus The Descartes Systems Group Inc. 's 1. 53x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACM Research, Inc. (ACMR) trades at 29. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 32. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IBTA: 121. 7% to $81. 38.
08Which pays a better dividend — IBTA or ACMR or DSGX or ICHR?
In this comparison, ACMR (0.
2% yield) pays a dividend. IBTA, DSGX, ICHR do not pay a meaningful dividend and should not be held primarily for income.
09Is IBTA or ACMR or DSGX or ICHR better for a retirement portfolio?
For long-horizon retirement investors, The Descartes Systems Group Inc.
(DSGX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), +295. 4% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DSGX: +295. 4%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IBTA and ACMR and DSGX and ICHR?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IBTA is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; DSGX is a small-cap quality compounder stock; ICHR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.